InterCardioRisk: a novel online tool for estimating doses of ionising radiation to occupationally-exposed medical staff and their associated health risks by Moriña, David et al.
InterCardioRisk: A novel online tool for estimating
doses of ionising radiation to occupationally-exposed
medical staff and their associated health risks
David Morin˜a1,2,3,4,5, James Grellier1,2,3,6, Adela Carnicer7,
Eileen Pernot2,3,4, Nick Ryckx7, Elisabeth Cardis2,3,4
1ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona,
Spain
2Universitat Pompeu Fabra (UPF), Barcelona, Spain
3CIBER Epidemiolog´ıa y Salud Pu´blica (CIBERESP), Barcelona, Spain
4Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program
(CERP), Catalan Institute of Oncology (ICO)-IDIBELL, L’Hospitalet de Llobregat,
Barcelona, Spain
5Grups de Recerca d’A`frica i Ame`rica Llatines (GRAAL) - Unitat de Bioestad´ıstica,
Facultat de Medicina, Universitat Auto`noma de Barcelona, Bellaterra 08193, Spain
6Department of Epidemiology and Biostatistics, Imperial College, London, UK
7Institute of Radiation Physics (IRA), Department of Radiology, Centre Hospitalier
Universitaire Vaudois (CHUV), Lausanne, Switzerland
E-mail: dmorina@creal.cat
Abstract. Those working in interventional cardiology and related medical
procedures are potentially subject to considerable exposure to X-rays. Two types
of tissue of particular concern that may receive considerable doses during such
procedures are the lens of the eye and the brain. Ocular radiation exposure results
in lens changes that, with time, may progress to partial or total lens opacification
(cataracts). In the early stages, such opacities do not result in visual disability;
the severity of such changes tends to increase progressively with dose and time until
vision is impaired and cataract surgery is required. Scattered radiation doses to the
eye lens of an interventional cardiologist in typical working conditions can exceed
34 µGy/min in high-dose fluoroscopy modes and 3 µGy per image during image
acquisition (instantaneous rate values) when radiation protection tools are not used.
A causal relation between exposure to ionising radiation and increased risk of brain
and central nervous system tumours has been shown in a number of studies. Although
absorbed doses to the brain in interventional cardiology procedures are lower than
those to the eye lens by a factor between 3.40 and 8.08 according to our simulations,
doses to both tissues are among the highest occupational radiation doses documented
for medical staff whose work involves exposures to X-rays. We present InterCardioRisk,
a tool featuring an easy-to-use web interface that provides a general estimation of both
cumulated absorbed doses experienced by medical staff exposed in the interventional
cardiology setting and their estimated associated health risks. The tool is available at
http://intercardiorisk.creal.cat.
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1. Introduction
Interventional cardiology (IC) comprises a variety of minimally-invasive procedures
used in the diagnosis and treatment of cardiovascular disease. In fluoroscopy, a key
technology used in this work, hard X-rays (photon energies typically above 5-10 keV)
are passed through a patient onto a detector; catheters and contrast agents are used
thereby allowing real-time visualisation of internal structures, processes and activities
[1]. Since interventional cardiologists and electrophysiologists carry out their work in
close proximity to the patient on whom the imaging is being carried out, they are
exposed occupationally to ionising radiation (IR) under normal working conditions.
Used appropriately to support a variety of procedures, IC provides enormous
clinical benefits over other surgical procedures, including minimal invasiveness, reduced
pain and risk of complications, shorter hospital stays, and lower costs [2, 3]. The
benefits of catheterisation over open surgery have resulted in a considerable increase
in workloads for IC staff over the past two decades and, although concomitant
improvements in technology and radiation protection (RP) measures have reduced doses
per procedure, there is concern that higher cumulated doses result in increased risks
to IC staff (particularly surgeons) of cataracts and may increase the risk of brain
tumours [4]. Effective use of RP measures can reduce doses to exposed organs and
thereby lower the magnitude of associated health risks. Doses to both the patient and
IC staff can be lowered via configuration of the fluoroscope. Doses to IC staff are
typically reduced through personal use of lead (or lead equivalent) aprons and thyroid
shields. International best practice recommendations state that physicians involved in
interventional procedures should wear such an apron, a thyroid shield and leaded eyewear
as a minimum set of RP measures [5], and these are currently used routinely in most
IC procedures. A number of additional protection measures may, however, be employed
to further reduce operator doses. As well as personal protective equipment such as lead
caps, several radiation shielding devices may be employed, including flexible blanket-
type shields laid over the patient during interventions to reduce operator exposure to
scattered radiation, table skirts (screens suspended between the operating table and
the floor), RP cabins (several screens assembled so as to surround the operator, with
apertures for the hands), and ceiling-suspended screens (manoeuverable screens that can
be pulled down in front of the operator’s face) [6]. The degree to which such measures are
employed vary by procedure, specialisation, experience, individual, hospital and country.
There are differences in their availability as well: while table skirts and ceiling-suspended
screens are available in most IC environments, flexible blanket-type shields are not
commonly available and RP cabins are very seldom installed. It has been suggested
that such measures are not employed in all catheterisation laboratories, possibly due,
in part, to the lack of available information and training in RP [7]. This is especially
true for those protection measures that are widely available such as table skirts and
InterCardioRisk: Occupational exposure to ionising radiation 3
ceiling-suspended screens. The latter is probably the most important item of protection
for the head. In some cases, impracticability, discomfort and occupational back pain
may also play a role in IC staff not employing certain measures. Recent substitution of
lightweight high atomic number materials for the heavier lead used in protective clothing
has reduced discomfort for personnel and increased compliance [8]. Given typical RP
practices at the present time, the organs of operators that remain chiefly exposed are
those in the head, including the eyes and the brain. This gives cause for concern, since
IR is known to have the potential for causing damage to these tissues.
Scattered radiation doses to the eye lens of an interventional cardiologist in typical
working conditions can exceed 34 µGy/min in high-dose fluoroscopy modes and 3
µGy per image during image acquisition (instantaneous rate values) when radiation
protection tools are not used [9]. Radiation-induced cataract has been recognised as a
highly relevant non-cancer endpoint among those exposed to IR since the 1930s [10].
Radiation-induced cataracts typically develop as central opacities in the subcapsular
posterior region of the lens, and consist of small granules and vacuoles that form
a roughly circular opacity. Defects in lens transparency cause little or no visual
impairment in the early stages of the disease, but eventually cause distortion and
clouding. The reaction of the lens to radiation is partly attributable to lifelong continued
differentiation of the epithelial cells that make up the lens (fibrogenesis); aberrant
differentiation of cells due to exposure to radiation results in their accretion to the
superficial posterior cortex [11].
Primary tumours of the central nervous system (CNS) include tumours, both
malignant and benign, of the brain, brain stem and spinal cord. The epidemiological
literature provides clear evidence for a causal association between brain tumours and
exposures to IR [12, 13]. Although some of the available literature supporting this
association relate to childhood exposures to low linear energy transfer (LET) radiation
(such as X-rays) [14], studies of the Japanese atomic bomb survivors indicate increased
risks of various CNS tumours (mainly brain tumours) characterised by linear dose-
response in adults [15].
Accurate estimation of health impacts to medical staff from IR under a variety of
operational and RP scenarios is increasingly important as use of IC procedures continues
to grow. Of the existing online radiation risk assessment tools, the majority are focused
on radiation exposures to the general population or to medical patients undergoing
specific diagnostic or radiotherapeutic procedures, and tend to provide estimates of
cancer risk only [16, 17]. Our primary objective was to produce a tool that estimates
the most relevant organ doses in IC staff occupationally exposed to radiation, and to
estimate the associated health impacts due to these exposures taking into account all
sources of uncertainty, specifically in terms of the risk of cataracts and brain tumours.
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2. Methods
We designed a tool that produces distributions of annual and total cumulated absorbed
doses to the brain and eye lens by employing robust estimators of parameters [18] based
on a multiple linear regression of predictors of dose, and subsequently estimates risk
based on published epidemiological data.
We developed the tool in R [19] using the shiny package [20], which allows
construction of interactive web applications from R and provides an easy-to-use web
front-end. The user interface (Figure 1) comprises two panels, positioned side by side.
In the left-hand “input” panel, the users can introduce specific data concerning their
career (profession, work period and annual numbers of procedures), the target organ of
interest (brain or eye lens), and the required output in terms of either absorbed dose
(in mGy) or associated health risk. Results are automatically generated and presented
in the right-hand “output” panel.
Figure 1. Screenshot of the web-based tool, showing the estimated absorbed dose (in
mGy) to the eye lens for an interventional cardiologist, under the “Typical working
practices” scenario.
The output panel is further divided into five tabs, the first three presenting the user
with organ-specific absorbed doses to the eye lens or brain (in mGy), and the associated
risk of cataracts and CNS tumours, respectively. These tabs correspond to dose and risk
estimates under different RP scenarios, namely (a) “Typical working practices”; (b) “No
radiation protection measures used”; and (c) “Protective equipment fully employed” -
a career during which all RP measures typically available throughout that time period
were used. Absorbed doses are presented both annually and cumulated across the whole
career, together with 95% credibility intervals. The fourth tab presents the cumulated
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doses and risk estimates for each of the three scenarios side by side, thereby facilitating
comparison of the potential impacts on dose and risk of employing RP measures. The
last tab presents a summary of the underlying assumptions employed by the tool in its
calculations. In addition to the web version of the results, the user can download a
summary report in PDF format that includes all input data and results.
An eye lens dose prediction model was built using data collected in the ORAMED
(Optimization of RAdiation protection for MEDical staff) project—described in
section 2.1—and from the literature, together with the user-defined occupational history.
The potential predictors of absorbed dose to the eye lens included the usage of RP
measures, catheterisation access route, tube configuration and operator experience.
It was considered unduly cumbersome to input precise details of every cardiological
procedure carried out over a career. Instead, the tool was designed so that the user
is required to specify only annual numbers of interventions carried out during their
career (via a graphical interface), and an occupational history is reconstructed using
the proportion of procedures reported as typical for France across each decade between
1970 and 2010 [21], in the absence of country-specific data. For the “typical working
practices” career scenario, the occupational history is reconstructed also assuming the
RP practices typical amongst French cardiologists over the same time period. For the
other two scenarios, the amount of RP practices incorporated into dose calculations
is altered accordingly. Changes in dose area product (DAP) typically available to
interventional cardiologists over the past four decades were taken into account by fitting
a metaregression model using results from the literature [22–34], and subsequently
adjusting the computed doses using these values. Probability distributions of measures
of risk under each scenario are calculated on the basis of the resulting cumulated
absorbed doses, using estimates of dose-response and related uncertainties derived from
the epidemiological literature (described in section 2.3). Various sources of uncertainty
are taken into account by means of Monte Carlo simulation, which allows uncertainties
in several model inputs to be propagated through to results, and thereby expressed as
95% credibility intervals on estimates of dose and risk.
2.1. Data
The data used for fitting the dose prediction model were collected previously within
the framework of the ORAMED project, a collaborative project funded in 2008 by
the European Union under its 7th Framework Programme. Its remit included the
development of methodologies for better assessing and reducing exposures to medical
staff from procedures that potentially result in large radiation doses or are associated
with complex radiation fields, such as those used in fluoroscopically guided procedures
and nuclear medicine. The project collected information on the doses incurred to
the eyes and the extremities of operators during IC and electrophysiology procedures
in seven European countries (Belgium, Greece, France, Italy, Poland, Slovakia and
Switzerland) through a measurement campaign. In total, 381 such procedures
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were monitored, including coronary angiography (CA) and percutaneous transluminal
coronary angioplasty (PTCA), radiofrequency (RF) ablations and pacemakers and
cardiac defibrillator implantations (PM/ICD). For each type of procedure, detailed data
were collected on the configuration of the X-ray tube employed, the degree of usage of RP
measures, and operator experience. These data are the most extensive data (in terms
of number of monitored procedures and countries included) so far collected through
measurements following a common protocol [35].
2.2. Dose estimation
Doses to the eye lens were estimated by means of a robust linear regression model on
the basis of ORAMED data (dose per unit DAP considering the most exposed eye),
including usage of table skirt, cabin and ceiling screen, on the type of procedure, on
tube configuration, and on operator experience (defined as high after 4 years of working
in IC or electrophysiology) as predictors of the absorbed dose. The obtained estimates
are shown in Table 1.
βˆ0 (95% CI)
Intercept 1.031 (0.56; 1.51)
Protection method βˆ (95% CI)
Table -0.011 (-0.369; 0.346)
Screen -0.486 (-0.788; -0.184)
Cabin -0.648 (-1.118; -0.177)
Procedure βˆ (95% CI)
CA PTCA Reference
PM/ICD 0.610 (0.225; 0.995)
RF ablation -0.025 (-0.355; 0.305)
Tube configuration βˆ (95% CI)
Above Reference
Below -0.869 (-1.249; -0.489)
Biplane -1.183 (-1.681; -0.684)
Experience βˆ (95% CI)
High Reference
Low 0.057 (-0.178; 0.293)
Table 1. Parameter estimates and confidence intervals
For instance, the dose estimated by the model for an interventionalist with relatively
little work experience, using a biplane tube configuration and conducting a CA
intervention, protected only by screen and table is exp(1.031 + 0.057− 1.183− 0.486−
0.011) = 0.55µSv/Gy ·cm2. The corresponding average dose in the ORAMED database
is 0.52µSv/Gy · cm2.
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In theory, dose to the eye lens is typically reduced by a factor of around 30 when
0.5mm lead-equivalent eyewear are used, but this degree of attenuation is only achieved
under frontal exposure to non-scattered radiation. In reality, interventionalists tend
to position themselves sideways to the primary beam, are also subjected to scattered
radiation emitted from the patient, and coverage of the eye may be reduced due to poor
eyewear fit [36]. The reduction factor of absorbed dose to the eye lens due to the usage
of protective eyewear was therefore assumed to follow a Project Evaluation and Review
Techniques (PERT) distribution [37] with minimal, modal and maximal values of 1, 3
and 10 respectively, based on expert opinion and a review of the literature [8, 38–40].
The PERT distribution is a particular case of the Beta distribution, characterized by
the density function
f(x) =

xα−1(1−x)β−1
B(α,β)
: 0 ≤ x ≤ 1
0 : Otherwise
where B(α, β) is the beta function, defined by
B(α, β) =
∫ 1
0
yα−1(1− y)β−1dy. (1)
Sampling from the beta distribution requires minimum and maximum values (scale)
and two shape parameters, α and β. The PERT distribution uses the mode or most likely
parameter to generate the shape parameters α and β. An additional scale parameter
λ scales the height of the distribution; the default value for this parameter is 4. In the
PERT distribution, the mean µ is calculated as
µ =
min+max+ λ ·mode
λ+ 2
(2)
And it can be used to compute the Beta distribution parameters α and β:
α = (µ−min)·(2mode−min−max)
(mode−µ)·(max−min)
β = α·(max−µ)
µ−min
(3)
The PERT distribution was preferred over the triangular distribution, which is
commonly used to model data elicited from experts or assembled from a variety of
published courses, as it does not suffer the same potential for systematic bias [37]. Like
the triangular distribution, the PERT distribution emphasizes the “most likely” value
over the minimum and maximum estimates. However, unlike the triangular distribution
the PERT distribution constructs a smooth curve which places progressively more
emphasis on values around (near) the most likely value, rather than on values around
the edges.
The considered PERT distribution profile is shown in Figure 2.
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Figure 2. Profile of a PERT distribution with minimum 1, maximum 10 and mode 3.
The metaregression model fitted to incorporate the changes in DAP over time was
893.34 − 0.43 · year. Therefore, the estimated dose in µSv/Gy · cm2 is multiplied by
the corresponding factor taking into account the year to obtain an estimated dose per
procedure (in µSv). This dose is finally multiplied by the number of procedures carried
out that year by the user and converted into mGy to be reported by the tool.
Doses to the brain were estimated as a function of modelled eye lens dose assuming a
linear relationship. This function was estimated by way of carrying out measurements in
a typical angiography room. Doses were measured using thermoluminescent dosimeters
(TLD) in a CIRS 702-D anthropomorphic female phantom, which was draped with a
lead apron and a thyroid shield, and positioned laterally to a single flat panel detector
(Philips Allura XPer FD10)(Figure 3). The patient was simulated with polymethyl
methacrylate (PMMA) slabs assembled as a rectangular cuboid of dimensions 25.2 cm
x 20 cm x 40.5 cm. Eleven TLDs were used for brain dosimetry (distributed across four
2.5 cm slabs), and 2 TLDs were used to measure doses to the eye lens. Absorbed doses
were measured for the eyes and for the brain (those parts considered most relevant
in terms of tumours). The ratios between each measured eye dose and a brain dose
weighted on the volumes of individual anatomical regions in which the TLDs were
placed, were calculated for use as a conversion factor from eye dose to brain dose. This
conversion factor was found to be between 3.40 (eye furthest from fluoroscope) and 8.08
(eye closest to fluoroscope). Operators increasingly work from both sides of the patient
during procedures [1]. In order to account for uncertainties due to positioning of the
interventionalist in our estimation of brain dose, the conversion factor was defined as a
uniform distribution between 3.40 and 8.08.
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Figure 3. Set-up of anthropomorphic phantom in angiography room.
2.3. Risk estimation
In addition to providing estimates of dose to the eye lens and to the brain, the tool also
provides the user with estimates of the magnitude of health impacts associated with
cumulated doses of IR, specifically in terms of the relative risk (RR) of radiation-related
cataracts and the lifetime fractional risk (LFR) of CNS tumours, a measure that scales
the lifetime attributable risk (LAR) to the lifetime spontaneous cancer incidence or
mortality [41]. For the sake of internal consistency and to ease comparisons to other
studies, RR of CNS tumours are also shown.
In the case of the eye lens, we calculated a dose-response coefficient for stage
1 to 5 cataracts, by scaling summary risk estimates at 1 Gy derived from the
epidemiological literature [11] (Odds Ratio: 1.70; 95% confidence intervals: 1.22, 1.38).
Using the published 95% confidence intervals for the summary risk estimates it was
possible to calculate the standard error (SE) and thereby define the dose-response
function probabilistically. Although the risk estimates at 1 Gy proposed in [11] were
obtained through a log-linear model, the excess relative risk model was preferred in
InterCardioRisk tool in order to ensure reasonable risk estimates at the highest doses.
The time between irradiation and the appearance of lens opacities is still uncertain
but nevertheless, early work on radiation-induced cataract among the atomic bomb
survivors showed an approximate average latency period for development of lens
opacities of 2-3 years [42, 43]. As we are quantifying risks of cataracts of a range of
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severities, starting from stage 1, which are just minor changes in the lens, lower severity
than those studied in atomic bomb survivors, we considered a lag of 5 years.
By way of Monte Carlo simulation, the tool uses the dose-response function and the
scenario-specific distributions of cumulated absorbed dose to the eye lens to calculate a
distribution of RR under each scenario.
The LFR of CNS tumours was estimated using the methods developed by the BEIR
VII committee [44] and data from the 1958-98 Life Span Study data [45], as was carried
out in developing the NCI RadRAT tool [16]. This is computed as LFR = LAR
B
, where
B =
∫ 110
0 m(a)S(a) is the baseline risk for a general population (m(a) is the background
cancer incidence in the European population) and LAR is the lifetime attributable risk,
computed as suggested by the BEIR VII committee:
LAR =
∫ 110
e+L βsDe
γe∗
(
a
60
)ν S(a)
S(e)
DDREF
, (4)
where e is the age at exposure, e∗ = e−30
10
if e < 30 or e∗ = 0 otherwise, a is
the attained age and according to the BEIR VII committee and [16], βs = 0.71, 0.24
for males and females respectively, γ = −0.3 and ν = −1.4. L is the latency period,
considered to be of 5 years for all solid cancer by BEIR VII committee. S(a)
S(e)
is the
probability of being alive at age a, given that an individual is alive at age e, and D is
the estimated dose. The approach used here for dose and dose-rate effectiveness factor
(DDREF) is the same that was used in [16], i.e. described by a lognormal distribution
with a geometric mean of 1.5 and a geometric standard deviation of 1.35. LAR can be
understood as an approximation to the premature probability of developing a cancer
that can be attributed to radiation exposure, while LFR is useful because it is a relative
number. Uncertainty in the LAR definition parameters (4) have been taken into account
by means of Monte Carlo simulation.
The RR of CNS tumours are calculated according the values reported in [12].
3. Results
The tool provides us with a means to estimate the cumulated absorbed doses to the eye
lens and brain (in mGy)—and associated health risks—under the three scenarios, and
easily make comparisons between them. As an example, we can estimate the doses and
health risks for a “typical” male interventional cardiologist born in 1960, who worked
from 1985 to 2014, carrying out 300 procedures per year between 1985 and 2000, and
then 350 per year until 2014. Distributions of cumulated absorbed doses to eye lens
and brain under the three RP scenarios (“Typical working practices”, “No radiation
protection measures used”, and “Protective equipment fully employed”) are presented
as histograms (Figure 4).
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Figure 4. Estimated probability density function of distributions of cumulated
absorbed doses (mGy) to the eye lens (upper panel) and brain (lower panel), for a
typical cardiologist working between 1985 and 2014.
Median annual absorbed doses for each scenario (Figure 5) are also presented by the
tool in tabulated form, along with 95% credibility intervals (CI). The figure illustrates
an increase in dose of about 15% - 20% (depending on the scenario) after 2000 due to
increased workload (from 300 annual procedures to 350). It also reflects the impact of
the introduction of new radiation protection measures, for instance a large reduction in
annual absorbed doses can be seen in 1990, when an increase of 25% in the usage of lead
glasses is assumed. In this example, the estimated total cumulated absorbed lens dose
is about 200 mGy (95% CI: 40, 645) under the “typical working practices” scenario. If
no protection methods are used, these values are increased to 380 mGy (95% CI: 200,
800). In the scenario under the usage of all available protection methods, the estimated
dose is 40 mGy (95% CI: 10, 140). The resulting differences in estimated health risks
calculated for the three scenarios are shown in Table 2.
It is clear that the use of protection methods has a great impact on reducing
cumulated absorbed doses to the eye lens and, subsequently, on reducing the risk of
cataracts. If we compare the doses to the eye lens incurred under a scenario in which no
protection methods are used at all, these impacts become all the more apparent. The
user can also see the difference between the different protection methods usage scenarios
on the cataract risk. For example, Figure 6 shows the difference in the distribution of
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RR and LFR of CNS tumours and RR of stage 1-5 cataracts.
Outcome Scenario Measure of risk Estimate (95% CI)
Stage 1-5 cataracts
Typical working practices
Protective equipment fully employed
No radiation protection measures used
RR
1.11 (1.02, 1.51)
1.02 (1.01, 1.10)
1.22 (1.09, 1.58)
CNS tumours
Typical working practices
Protective equipment fully employed
No radiation protection measures used
RR
1.05 (1.01, 1.30)
1.01 (1.00, 1.06)
1.10 (1.02, 1.44)
CNS tumours
Typical working practices
Protective equipment fully employed
No radiation protection measures used
LFR
1.00 (1.00, 1.01)
1.00 (1.00, 1.00)
1.01 (1.00, 1.02)
Table 2. Estimates of potential health risks for the three different RP scenarios,
in terms of relative risks of cataracts for doses to the eye lens and RR and lifetime
fractional risk (LFR) for CNS tumours, for a typical cardiologist working between 1985
and 2014.
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Figure 5. Annual absorbed doses (mGy) to eye lens (upper panel) and brain (lower
panel), for a typical cardiologist working between 1985 and 2014.
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Figure 6. Estimated probability density function of distributions of stage 1-5
cataracts RR (upper panel) and CNS tumours RR and LFR (lower panel) for a typical
cardiologist working between 1985 and 2014.
4. Discussion
We developed a novel tool, InterCardioRisk, that allows IC personnel to estimate their
annual and cumulated doses to the eye lens and brain, and associated potential health
impacts in terms of risk of cataracts and CNS tumours. Specifically, the tool allows
the user to compare estimated doses to a worker with a typical career and typical
use of RP measures, and the associated estimated risks of cataract and CNS tumour,
with the reductions in dose expected where protective equipment is employed to the
maximum possible extent. By extension, the output of the tool allows for estimation
of the expected health benefits for that population associated with increased use of
available RP measures. The InterCardioRisk tool directly supports the aims of RP, and
would make a useful addition to the RP training of those working in IC. In particular, the
use of LFR as the risk metric facilitates direct comparison with the lifetime cancer risk of
a person of the same age and sex in the general population. For those already employing
RP practices effectively in their work, the small magnitude of increased risks serves as a
reassurance that they are successfully minimising their occupational exposure. By the
same token, those not following RP guidelines may be motivated towards employing RP
measures to reduce their cumulated doses and attendant health risks.
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Cumulative eye lens doses estimated by the InterCardioRisk tool are consistent
with the results of the French O’CLOC study [21]. This study presented a
retrospective assessment of cumulative eye lens doses for interventional cardiologists and
electrophisiologists using dose data from the ORAMED project, as well as information
on the workload, radiation protection equipment and dose reduction factors. The
authors reported a median cumulative eye lens dose of 309 mSv, ranging from 25 mSv
to more than 1600 mSv, for 129 interventional cardiologists at an average age of 51 who
had worked for an average period of 22 years, similar to the estimates provided by the
InterCardioRisk tool using Jacob’s data under the typical working practices scenario
(median of 314 mSv, with a credibility interval of (61 mSv - 1142 mSv)). In contrast
with these dose levels, other studies report cumulative eye lens doses significantly
higher. These studies are based on a different, common methodology [46–49], using
experimental data of scattered dose factors per unit DAP measured with electronic
dosemeters, corrected by the operator position and the use of protective devices, and
reported workload. Cumulative eye lens doses reported in these works are of 6 Sv (100
mSv - 27 Sv) (median value, average age of 46, average working period of 14 years)
[46], 3.7 Gy (20 mGy - 43 Gy) (mean value, average age of 42, average working period
of 9.2 years) [48] and 420 mSv (46 mSv - 7.3 Sv) (median, average age of 43, average
working period of 8 years) [49]. These values lead to average annual doses ranging
from 53 mSv to 429 mSv, in contrast with an annual dose of 14 mSv issued from
InterCardioRisk and Jacob’s paper. The different doses estimated by each methodology
fall within the large ranges of dose reported in the literature. The variation in reported
doses is associated with the high degree of uncertainty in measurements of lens dose,
with different methodologies used, and the assumptions used to extrapolate eye doses
from other dose measures [50]. However, we consider that estimates based on ORAMED
measurement campaign are likely to provide more realistic outcomes because doses were
measured under real conditions.
There have been several reports made regarding radiation-induced cataract in ICs
who have performed procedures for a number of years, and of equivalent doses to the
lens approaching the annual limit of 150 mSv during angiographic procedures [46, 51–
53]. Recent studies have shown that under typical workloads of an IC, the radiation
dose to the lens may exceed the current threshold for tissue reactions after several
years of work if radiological protection devices are not used and radiological protection
principles are not followed [6, 51]. Several surveys of cardiologists and support staff
working in catheterisation laboratories, conducted with co-ordination provided by the
International Atomic Energy Agency (IAEA) in Latin America and Asia, have found
a high prevalence of lens opacities of the type associated with occupational radiation
exposure [48,51]. These recent data and the mechanistic uncertainties regarding cataract
development highlighted the need for a detailed re-appraisal of the radiosensitivity of
the lens of the eye. This issue is addressed in Publication 118 of the ICRP and in
the Commission’s statement on tissue reactions [54, 55]. The previous Commission
recommendation [56] of an equivalent dose limit of 150 mSv/y for occupational exposure
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in a planned exposure situation (e.g. occupational exposure of interventionalists) has
been changed. The Commission now recommends that the lens-equivalent dose limit
for chronic occupational exposure should be 20 mSv/y, averaged over a defined 5-
year period, with no single year exceeding 50 mSv (i. e. the same as the annual
whole-body limit for workers) [54, 55]. Note that a study performed with data from
1984 through 1988, when both cardiac interventions and fluoroscopic equipment were
less sophisticated than they are now, determined that the annual equivalent dose to
cardiologists’ heads was approximately 20–30 mSv [57]. The Commission considers the
threshold for absorbed dose to the lens of the eye to be 0.5 Gy [54]. The Commission
judges, based on existing evidence, that an acute dose of up to around 0.1 Gy (100
mGy) produces no functional impairment of tissues, including the lens of the eye with
respect to cataract, although the use of a threshold model remains uncertain for this
tissue [54].
As the degree of usage of available RP measures determines an operator’s absorbed
dose to a great extent, our tool provides an invaluable means for an individual to quantify
the efficacy of using those measures in their daily practice. Some RP measures like
cabins are not generally available or usable.However, very appreciable reductions in
absorbed doses can be attained through using the most common protection measures
properly, in particular lead glasses and ceiling-suspended screens. The presentation of
the estimates of absorbed dose in the various scenarios side by side exemplifies the
very real importance of making use of the measures available to reduce dose, further
supported by estimation of the associated health risks. The most important sources of
uncertainty are taken into account through Monte Carlo simulation, thereby showing
these outputs as ranges. Upon identifying a high rate of radiation lens injuries in
a population of Colombian interventional cardiologists [46], the authors highlight the
urgent need to take appropriate action to increase the use protective measures and
strengthen training programmes in RP. Tools such as the one presented in this work
can be useful for this purpose, as the difference in absorbed dose and associated health
risks between the distinct scenarios of use of protective measures is easily quantified.
Although treatment of cataracts is a relatively straightforward procedure nowadays, this
should not encourage interventional cardiologists to take an increased risk of cataracts
lightly: not all operations to remove cataracts are successful, and complications may
result in irreversible opacities which could diminish a surgeon’s ability to continue with
their work.
5. Limitations
We consider that the outputs of InterCardioRisk tool are of potentially great usefulness
to the IC and RP communities, but with some limitations. Relatively sparse historical
data were available on working practices—both in terms of IC procedures and RP
measures taken—so estimates of dose made by the tool may be inaccurate when
used in those working environments where practices over the past 40 decades have
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differed greatly to those common in France. Also, it is conceivable that as cardiologists
progress through their careers, they may increasingly focus on a particular type of
intervention. This may also result in divergence between their true cumulated dose
and those estimated by the tool. For example, those working in paediatric IC may be
required to work much closer to the X-ray beam due to the size of the patient, and
as a result have higher doses. Similarly, those working predominantly in emergency
interventional treatment of heart attacks have less time to configure radiation shields
prior to catheterisation.
The tool predicts various kind of cataracts at all stages of development from stage
1—defined as discrete posterior subcapsular cataract (PSC) or cortical opacity in a
small area of the lens—to stage 5—defined as a mature cataract with complete lens
opacification. This is a broad definition, and includes a variety of different kinds of
cataract, each of which has a different pathogenesis and prognosis. IR has been found
to be most strongly associated with PSC formation [10,58]. Unlike age-related cortical
or nuclear cataracts, which primarily cause a change in visual acuity, a PSC cataract is
more likely to result in changes in both visual acuity and contrast sensitivity [59]. The
RR of radiation-induced PSC cataracts is somewhat higher than that of other kinds of
cataract, hence the tool may be slightly underestimating the risk of cataract specifically
related to radiation dose.
Evidently, the validity of our assumption that OR is a good estimate of the RR is
dependent on the incidence of the health outcome of interest in the unexposed population
(i.e. the baseline rate). Although such an assumption is reasonable for rare outcomes
such as cancers, the high incidence of cataracts in the unexposed population results in
a slight overestimation of the risk of cataracts when using OR to estimate measures of
risk and health impact. It was not possible to adjust the ORs using baseline rates as
reliable baseline rates of the specific cataract types of interest were not available for
European populations. We simulated the effect of using the OR in place of the RR
on our estimates of health impact for a number of baseline rate scenarios. If baseline
rates of stage 1-5 cataracts were 25%, we estimated that our risk estimate might be
overestimated by less than 10%. The OR reported in [11] are obtained from Chernobyl
clean-up workers, and although these are the most comprehensive estimates to date, and
are compatible with those obtained from studies of surgically removed cataracts in the
atomic bomb survivors study [45], there are issues concerning the adequacy of current
dosimetric estimates.
In order to calculate a dose conversion factor between absorbed dose to the eye
lens and absorbed dose to the brain, it was necessary to make a number of relatively
crude simplifications. TLDs were positioned only in some of the anatomical regions of
the brain, and dose was averaged over those regions using their approximate sizes as
weights. When combining the brain dose data with dose-response and population data
on cancer incidence in the calculation of LFR, it was necessary to assume that the brain
and the whole CNS could be considered as “equivalent”, in the sense that dose-response
and incidence data were only available for brain/CNS tumours combined. Any dose
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estimate to the brain is therefore considered to be valid for the CNS; when considering
the CNS as a whole, it is therefore possible that dose has been overestimated. Since the
majority of CNS tumours occur in the brain, however, and that the brain makes up the
greater part of the CNS, we do not imagine that this overestimation has a large impact
on the estimates of CNS tumour risk generated by the tool.
6. Recommendations for further work
Following discussions with cardiologists and RP staff, a number of improvements and
extensions are planned for the tool. In particular, we would like to include the estimation
of absorbed doses for other organs and calculation of risks for other endpoints. Extension
of the tool to include other measures of health impact would be merited as a means of
maximising the population for which the tool provides useful information. For example,
it would be possible to estimate the total disability-adjusted life years (DALYs) for the
health outcomes considered. Although not without its drawbacks, the use of DALYs
allows for the synthesis and comparison of health impacts due to multiple diseases
within a single framework. Currently, it is far from clear which metric might best
communicate the gravity of potential health impacts to the target populations of interest
i.e. interventional cardiologists, electrophysiologists and RP staff in hospitals. Further
work on quantifying the efficacy of the tool to communicate health impacts to IC staff is
necessary in order to refine it. A pilot version of the tool was sent to a group of over 100
experts in RP, medical radiation dosimetry and IC together with an online questionnaire
designed to gauge their opinions on the user-friendliness of the tool, their perceptions
of the magnitude of estimated doses, and the tool’s usefulness in terms of improving
compliance with RP guidelines and, ultimately, in reducing potential health impacts,
and as a perspective to this work, with the aim of keeping the tool updated with the
current standard procedures and RP methods usage in IC, a survey will be prepared
including questions regarding the protection methods the IC use and their reasons for
not following all guidelines.
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